JARID1D selectively targets the promoters of genes implicated in invasion and metastasis, such as metalloproteinase (MMP)1 and MMP3, thereby diminishing the invasive capacity of tumor cells and impeding metastatic process 16. Here, KDM5D is linked to neoplasm.